Delta Asia International Corporation (TPEX:6762)
161.50
-11.50 (-6.65%)
At close: Feb 11, 2026
Delta Asia International Revenue
Delta Asia International had revenue of 175.52M TWD in the quarter ending September 30, 2025, with 5.97% growth. This brings the company's revenue in the last twelve months to 711.19M, up 39.69% year-over-year. In the year 2024, Delta Asia International had annual revenue of 580.51M with 14.27% growth.
Revenue (ttm)
711.19M
Revenue Growth
+39.69%
P/S Ratio
7.99
Revenue / Employee
3.89M
Employees
183
Market Cap
5.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 580.51M | 72.49M | 14.27% |
| Dec 31, 2023 | 508.02M | 45.05M | 9.73% |
| Dec 31, 2022 | 462.97M | -68.34M | -12.86% |
| Dec 31, 2021 | 531.32M | -23.00M | -4.15% |
| Dec 31, 2020 | 554.31M | 170.94M | 44.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| United Orthopedic | 5.46B |
| TaiDoc Technology | 4.34B |
| Hi-Clearance | 4.19B |
| InnoCare Optoelectronics | 2.18B |
| Dynamic Medical Technologies | 1.43B |
| WeLeader Biomedical | 1.06B |
| A Plus Biotechnology | 825.52M |
| Diamond Biotechnology | 698.11M |